Voss Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,100,000
Closed -$27.8M 73
2025
Q3
$27.8M Sell
1,100,000
-490,453
-31% -$12M 1.37% 22
2025
Q2
$38.2M Sell
1,590,453
-1,881,493
-54% -$43.6M 2.63% 15
2025
Q1
$79.5M Buy
3,471,946
+381,659
+12% +$9.21M 6.1% 8
2024
Q4
$78.2M Buy
3,090,287
+540,287
+21% +$13.7M 5.82% 6
2024
Q3
$63.6M Buy
2,550,000
+655,323
+35% +$19.4M 5.28% 6
2024
Q2
$56.2M Sell
1,894,677
-451,102
-19% -$12.5M 5.61% 5
2024
Q1
$70.7M Buy
+2,345,779
New +$65.1M 5.84% 5

Other funds holding RTO

Voss Capital's RTO Position: Q4 2025 in Review

Voss Capital sold out of Rentokil (RTO) in Q4 2025, closing a stake of 1,100,000 shares — an estimated $27.8M sold.

Voss Capital first reported a position in RTO in Q1 2024 and held it in 7 quarters. The position peaked at $79.5M in Q1 2025. 254 funds tracked by Wall St. Rank hold RTO as of Q4 2025.

  • Voss Capital reported no remaining Rentokil position as of Q4 2025 after selling out during the quarter.
  • Voss Capital sold 1,100,000 Rentokil shares in Q4 2025, an estimated $27.8M.
  • Voss Capital first reported a position in Rentokil in Q1 2024 and held it in 7 quarters.
  • Voss Capital's Rentokil position peaked at $79.5M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Rentokil as of Q4 2025.

Based on Voss Capital's 13F filing for Q4 2025, filed 13 Feb 2026.